Sunshine Biopharma (SBFM) Stock: Launches Amoxicillin in Canada With 12 More Drug Launches Planned for 2026

TLDR Sunshine Biopharma launches Amoxicillin in Canada as its generic portfolio expands. SBFM begins pharmacy shipments as Amoxicillin targets a $4.9 billion market. Sunshine Biopharma adds Amoxicillin while planning 12 more launches in 2026. SBFM expands its Canadian drug portfolio with Amoxicillin across several strengths. Sunshine Biopharma targets growth through Amoxicillin and new 2026 drug [...]

The post Sunshine Biopharma (SBFM) Stock: Launches Amoxicillin in Canada With 12 More Drug Launches Planned for 2026 appeared first on Blockonomi.